ClinicalTrials.Veeva

Menu

Comprehensive Lifestyle Change To Prevent Breast Cancer

M.D. Anderson Cancer Center logo

M.D. Anderson Cancer Center

Status

Active, not recruiting

Conditions

Premenopausal

Treatments

Other: Cancer Prevention
Other: Questionnaire Administration

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03448003
NCI-2018-00915 (Registry Identifier)
2017-0479 (Other Identifier)

Details and patient eligibility

About

This trial studies how well comprehensive lifestyle change works in preventing patients from breast cancer. A program including dietary recommendations, physical activity, stress management and mindfulness training, learning sleep hygiene techniques, and behavioral counseling in addition to social support may help patients who may be at risk for breast cancer.

Full description

PRIMARY OBJECTIVES:

I. Assess the feasibility of a randomized controlled trial involving a mobile, standardized, comprehensive integrative oncology (IO) prevention program.

SECONDARY OBJECTIVES:

I. Compare group differences over time in biological pathways including: immune function, gut microbiome, endocrine function, insulin and glucose metabolism, inflammation, other cancer-related pathways (from peripheral blood), antioxidant capacity, and nutrient levels.

II. Determine whether the IO group has improved patient reported outcomes over time including: quality of life, sleep disturbances, aspects of mental health, and psychosocial measures including: mindfulness, social support, and measures of positive growth.

III. Compare group differences over time in dietary patterns, fitness levels, percent body fat, and anthropometrics.

OUTLINE: Patients are randomized into 1 of 2 groups.

GROUP I: Patients attend IO prevention program consisting of 1-2 physical activity, nutrition and diet, and mind-body practice sessions over 60 minutes weekly for 12 weeks. Patients also attend a behavioral counseling session once weekly for up to 26 weeks. Patients complete exercises over 30-60 minutes 3-5 times weekly for 12 weeks.

GROUP II: Patients receive no intervention. After 26 weeks, patients may crossover to Group I.

After completion of study, patients are followed up at 26 weeks and 1 year.

Enrollment

60 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Able to read, write, and speak English
  • Premenopausal
  • A body mass index (BMI) >= 25
  • Have intact breasts and ovaries
  • Able to provide informed consent to participate in the study
  • Meet all the following criteria related to lifestyle: a) consume less than 3 servings of vegetables (excluding any fried servings) and 1 serving of fruit (not including juice)/day; b) engage in less than 150 minutes moderate/vigorous intensity activity per week, defined as anything that causes small increases in breathing or heart rate for a sustained amount of time (e.g., brisk walking, bicycling); c) engage in a mind-body practice less once per week
  • Able mentally and physically to participate in interventions in this study (Note: If there are one or more positive responses to the Physical Activity Readiness Questionnaire [PARQ], then a physician-release for exercise is required prior to obtaining consent)
  • Access to internet connection
  • Able to come to University of Texas (UT) MD Anderson for the orientation and assessment sessions

Exclusion criteria

  • Any personal history of cancer, including ductal carcinoma in situ (DCIS) and not including non-melanoma skin cancers
  • Any major thought disorder (e.g., schizophrenia, dementia)
  • Communication barriers (e.g. hard of hearing)
  • Poorly or uncontrolled diabetes in the opinion of the physician(s)
  • Being pregnant or planning on becoming pregnant within the next year
  • Contemplating any new pharmacologic/hormonal or prophylactic surgical intervention for breast cancer prevention within the next year (Note: Individuals taking tamoxifen, arimidex or other hormonal prevention strategies at time of consent will be eligible)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Group I (IO prevention program)
Experimental group
Description:
Patients attend IO prevention program consisting of 1-2 physical activity, nutrition and diet, and mind-body practice sessions over 60 minutes weekly for 12 weeks. Patients also attend a behavioral counseling session once weekly for up to 26 weeks. Patients complete exercises over 30-60 minutes 3-5 times weekly for 12 weeks.
Treatment:
Other: Questionnaire Administration
Other: Cancer Prevention
Group II (no intervention)
Active Comparator group
Description:
Patients receive no intervention. After 26 weeks, patients may crossover to Group I.
Treatment:
Other: Questionnaire Administration

Trial contacts and locations

1

Loading...

Central trial contact

Lorenzo Cohen, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems